156 related articles for article (PubMed ID: 17367162)
21. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
22. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
23. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
24. Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).
Hanke U; May K; Rozehnal V; Nagel S; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2010 Oct; 76(2):260-8. PubMed ID: 20600890
[TBL] [Abstract][Full Text] [Related]
25. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins.
Bogman K; Erne-Brand F; Alsenz J; Drewe J
J Pharm Sci; 2003 Jun; 92(6):1250-61. PubMed ID: 12761814
[TBL] [Abstract][Full Text] [Related]
26. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
Tatavarti A; Kesisoglou F
J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
[TBL] [Abstract][Full Text] [Related]
27. Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive.
Zhao HZ; Tan EC; Yung LY
J Biomed Mater Res A; 2008 Mar; 84(4):954-64. PubMed ID: 17647225
[TBL] [Abstract][Full Text] [Related]
28. Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.
Bittner B; Guenzi A; Fullhardt P; Zuercher G; González RC; Mountfield RJ
Arzneimittelforschung; 2002; 52(9):684-8. PubMed ID: 12404883
[TBL] [Abstract][Full Text] [Related]
29. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
Regev R; Assaraf YG; Eytan GD
Eur J Biochem; 1999 Jan; 259(1-2):18-24. PubMed ID: 9914470
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
31. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.
Youk HJ; Lee E; Choi MK; Lee YJ; Chung JH; Kim SH; Lee CH; Lim SJ
J Control Release; 2005 Sep; 107(1):43-52. PubMed ID: 16081183
[TBL] [Abstract][Full Text] [Related]
32. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities.
Orlowski S; Selosse MA; Boudon C; Micoud C; Mir LM; Belehradek J; Garrigos M
Cancer Biochem Biophys; 1998 Jun; 16(1-2):85-110. PubMed ID: 9923970
[TBL] [Abstract][Full Text] [Related]
33. Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs.
Zhao J; Feng SS
Biomaterials; 2014 Mar; 35(10):3340-7. PubMed ID: 24461325
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of phospholipids on P-glycoprotein: cellular studies in Caco-2, MDCKII mdr1 and MDCKII wildtype cells and P-gp ATPase activity measurements.
Simon S; Schubert R
Biochim Biophys Acta; 2012 Sep; 1821(9):1211-23. PubMed ID: 22691950
[TBL] [Abstract][Full Text] [Related]
35. A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.
Fan Z; Wu J; Fang X; Sha X
Int J Pharm; 2013 Mar; 445(1-2):141-7. PubMed ID: 23396256
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
Vilas-Boas V; Silva R; Nunes C; Reis S; Ferreira L; Vieira C; Carvalho F; Bastos Mde L; Remião F
Toxicol Lett; 2013 Jul; 220(3):259-66. PubMed ID: 23685082
[TBL] [Abstract][Full Text] [Related]
37. Application of TPGS in polymeric nanoparticulate drug delivery system.
Mu L; Seow PH
Colloids Surf B Biointerfaces; 2006 Jan; 47(1):90-7. PubMed ID: 16412619
[TBL] [Abstract][Full Text] [Related]
38. Using in situ Raman spectroscopy to study the drug precipitation inhibition and supersaturation mechanism of Vitamin E TPGS from self-emulsifying drug delivery systems (SEDDS).
Raut S; Karzuon B; Atef E
J Pharm Biomed Anal; 2015 May; 109():121-7. PubMed ID: 25767907
[TBL] [Abstract][Full Text] [Related]
39. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux.
Dabholkar RD; Sawant RM; Mongayt DA; Devarajan PV; Torchilin VP
Int J Pharm; 2006 Jun; 315(1-2):148-57. PubMed ID: 16616818
[TBL] [Abstract][Full Text] [Related]
40. Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide.
Beig A; Fine-Shamir N; Porat D; Lindley D; Miller JM; Dahan A
Eur J Pharm Biopharm; 2017 Dec; 121():97-103. PubMed ID: 28958946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
